#weight-loss

#weight-loss

Despite not being FDA-approved for weight loss, Ozempic is gaining popularity for this off-label use. [ more ]

Experts warn that the use of medications like Wegovy and Ozempic, popular for weight loss, may inadvertently lead to unexpected pregnancies due to improved fertility in women with obesity. [ more ]

Ozempic belongs to a class of GLP-1 receptor agonists, aiding weight loss and diabetes treatment with similar drugs like Wegovy, Mounjaro, and Zepbound. [ more ]

Ozempic shifted marketing towards weight loss despite lacking FDA approval. [ more ]

GLP-1 drugs like Ozempic and Wegovy have significant impact on weight loss and reducing the risk of heart disease, stroke, and other comorbidities. [ more ]

GLP-1 drugs like Ozempic show potential in reducing smoking and alcohol consumption due to their craving control mechanisms. [ more ]

A weight loss injection with semaglutide could reduce the risk of heart attacks, strokes, or death due to cardiovascular disease by 20%. [ more ]

Anti-obesity drug's benefits extend beyond weight loss to reducing cardiovascular risks. [ more ]

Technology alone led to worse weight loss compared to tech and a telehealth coach. [ more ]

Walking in New York can be euphoric or agonizing; lack of health insurance led to a challenging health journey with unexpected side effects. [ more ]

Spontaneous weight loss may be an early indicator of cancer.

Treating weight loss as an important vital sign may help doctors spot cancer earlier. [ more ]

Unintentional weight loss is associated with an increased risk of cancer diagnosis within a year.

Recent weight loss is significantly associated with an increased risk of several types of cancer. [ more ]

Genetic analysis can predict patient's response to semaglutide for weight loss, not effective for everyone. [ more ]

GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects. [ more ]

Patients on GLP-1 agonist medications for obesity may keep some weight off even after stopping the medication.

The new data provides a more nuanced picture of patient outcomes and contradicts previous studies suggesting that patients need to stay on the medication to maintain weight loss. [ more ]

Technology alone insufficient for effective weight loss without human support. [ more ]

GLP-1 drugs are effective but not instant weight loss solutions. They require lifestyle changes and patience for gradual, sustainable results. [ more ]

Avoid weight loss blunders by setting realistic goals, not skipping meals, prioritizing sleep, not fixating on the scale, and avoiding fad diets. [ more ]

Incorporate non-starchy vegetables, olive oil, full-fat dairy, nuts and seeds, and lean protein for weight loss. [ more ]

People on Wegovy experience steady weight loss for 65 weeks, maintaining initial loss over 4 years despite hitting a plateau. [ more ]

Weight loss on Wegovy plateaus after 65 weeks but is maintained over 4 years with a significant difference from the placebo group. [ more ]

Major health insurance companies in the U.S. are starting to cover Novo Nordisk's weight loss injection Wegovy.

The FDA approved Wegovy for heart health after a study showed it could reduce the risk of heart attack and stroke by 20%. [ more ]

Financial incentives and text messages can effectively motivate obese men to lose weight, with a 4.8% decrease in body weight observed in the group receiving both forms of motivation. [ more ]

Brown fat burns calories to produce heat, potentially aiding weight loss and health.

Research identifies an 'off switch' protein in brown fat limiting its activation against obesity. [ more ]

Semaglutide (Ozempic/Wegovy) may impact fertility due to its association with weight loss and metabolic improvements. [ more ]

Time-restricted eating for weight loss may work simply by helping people eat fewer calories overall. [ more ]

Doctors need to change their messaging to obese patients for better results in treating obesity.

The future of medicine aims to eradicate being overweight through new therapies, surgery, and funding for treatment. [ more ]

GLP-1 receptor agonists like Ozempic aid weight loss

Exercise can help prevent weight regain after discontinuing GLP-1 receptor agonists [ more ]

Kelly Clarkson credited a weight loss drug for her transformation. [ more ]

Kelly Clarkson is nominated for Best Pop Vocal Album at the Grammys.

Clarkson has undergone a drastic weight loss transformation. [ more ]

Kelly Clarkson attributes her weight loss to diet and exercise and denies using Ozempic for rapid weight loss.

Clarkson follows the Plant Paradox Diet and allows herself occasional indulgences. [ more ]

Intermittent fasting has gained popularity for weight loss and other health benefits, though its long-term effectiveness remains uncertain. [ more ]

Dry oats as a low-cost alternative for weight loss may not mimic the effects of prescription drugs like Ozempic, Wegovy, and Mounjaro.

Combining a meal replacement drink called 'oat-zempic' made from oats, lime, and water with intermittent fasting can aid in weight loss. [ more ]

Intermittent fasting and GLP-1 agents can be combined for weight loss in patients

GLP-1 agents are generally safe for kidney patients [ more ]

IF involves cycling between periods of eating and fasting, and it can lead to weight loss, improved insulin sensitivity, increased fat oxidation, and cellular repair.

For cyclists, IF can potentially lead to reduced body fat, enhanced fat burning, and improved metabolic health, but there are also potential drawbacks such as reduced energy availability during fasting periods. [ more ]

There are four basic principles for successful weight loss: portion control, drinking water, regular exercise, and getting enough sleep. [ more ]

Weight loss success relies on four basic principles: portion control, staying hydrated, regular exercise, and getting enough sleep. [ more ]

Zepbound, a weight loss drug, shows potential in treating obstructive sleep apnea, with trial results prompting Eli Lilly to seek FDA approval for expanded use. [ more ]

Tirzepatide, a rival to semaglutide, has been shown to improve blood pressure after 36 weeks of use.

Tirzepatide is already approved as a weight loss drug under the name Zepbound and as a diabetes medication under the name Mounjaro. [ more ]

On average, people attempt to lose weight seven times in their lifetime.

Common temptations causing setbacks include chocolate, crisps, cakes, and biscuits. [ more ]

Eating up to 10 meals per day may be beneficial for those with stomach issues or those trying to lose weight.

The quality of the foods consumed is important when eating smaller, frequent meals. [ more ]

Hunter Burn is the top pick for best fat burner for men in 2024.

Hunter Burn contains high-quality natural ingredients and offers a 100-day money-back guarantee. [ more ]

Scott Harrison's Six Pack Revolution program focuses on changing the relationship with food and detoxifying the body.

The program aims to create a body that works at its optimum, burning fuel efficiently and building and maintaining muscle mass. [ more ]

Novel GLP-1 drugs are revolutionary for weight loss and diabetes prevention.

Big Food's responsibility in necessitating these drugs is often overlooked. [ more ]

Health plans are imposing limits on coverage of GLP-1s for weight loss, with some states dropping coverage altogether.

North Carolina's health plan for state employees will no longer cover GLP-1s for weight loss due to high costs. [ more ]

GLP-1 drugs like Ozempic and Wegovy can help with weight loss and regulate blood sugar.

People who take GLP-1 drugs report feeling full for the first time and losing 10 to 20 percent of their body weight in the first year. [ more ]

A molecule produced after exercise causes weight loss with metformin

Understanding this molecule may lead to new weight loss drugs [ more ]

Samantha Abreu lost over 100 pounds by walking 10,000 steps a day and incorporating exercise into her routine.

Abreu's journey involved overcoming struggles with binge eating, lack of physical activity, and exhaustion from work while finding a new appreciation for movement and healthy habits. [ more ]

The FDA is investigating whether semaglutide, the active ingredient in the weight loss drug Wegovy and diabetes medication Ozempic, may cause hair loss and suicidal thoughts.

The FDA's Adverse Event Reporting Systems (FAERS) received reports of patients experiencing hair loss, suicidal ideation, and instances of aspiration while using GLP-1 drugs like semaglutide. [ more ]

A large U.S. study found no evidence of a link between Novo Nordisk's Ozempic and Wegovy and an increase in suicidal thoughts.

The study found that semaglutide, the active ingredient in Ozempic and Wegovy, actually had a lower risk of new and recurrent suicidal thoughts compared to other medications for weight loss or diabetes. [ more ]

No plan for a healthy lifestyle is one size fits all.

Remaining skeptical of health-related information is important. [ more ]

No plan for a healthy lifestyle is one size fits all.

Remaining skeptical of health-related information is important. [ more ]

The healthiest diets in 2024 have nothing to do with weight loss.

The Mediterranean diet is ranked as the best overall diet for the seventh consecutive year. [ more ]

The healthiest diets in 2024 have nothing to do with weight loss.

The Mediterranean diet is ranked as the best overall diet for the seventh consecutive year. [ more ]